About Us.
We provide support and hope to patients and families affected by autoimmune hepatitis (AIH) through disease education, community building, and research opportunities.
Our mission is to provide support and hope to patients and families affected by AIH through disease education and research opportunities.
From our national conferences and virtual support groups to COVID-19 programing and a new patient registry, we provide the most up-to-date information about autoimmune hepatitis, offer support, and drive research.
Our Board of Directors, staff, and Medical Advisory Board bring decades of expertise in a wide range of fields.
We support research that seeks to discover new and better treatments for autoimmune hepatitis and improve the quality of life for patients.
View our most recent annual report, and learn how we’re using your donations efficiently and effectively.
We greatly appreciate our members who have chosen to give a financial contribution to the AIHA. Our programs would not exist without your generosity!
Our Mission.
Our mission is to provide support and hope to patients and families affected by AIH through disease education and research opportunities.
Our Executive Director, Craig Lammert, M.D., established the AIHA in 2015 along with patient leaders from across the country. Dr. Lammert is a clinician and researcher at Indiana University School of Medicine who is funded by the National Institutes of Health to study AIH.
By pairing the expertise of a hepatologist with the firsthand experiences of patients, we create innovative and impactful programming that improves lives for families struggling with autoimmune hepatitis.
Core Initiatives.
From our national conferences and virtual support groups to COVID-19 programing and a patient registry, we provide the most up-to-date information about autoimmune hepatitis, offer support, and drive research. Our core initiatives include:
-
Our patient conference held every other year. To date, we’ve held three conferences with more than 500 attendees.
-
Educational videos and webinars, including the new COVID-19 Frontline Report series that provides the most up-to-date information about the pandemic and how it affects autoimmune liver disease patients.
-
Virtual support groups to bring patients and families together who are going through similar experiences.
-
Programming to help patients deal with depression, anxiety, fatigue, and poor sleep, common symptoms of AIH. We offered a mindfulness course at our most recent conference and are developing an online course to help patients improve sleep.
-
The AIHA patient registry, which launched in 2021, aims to drive research into new and better treatments that improve patients’ quality of life.
Thank You Donors.
Support
Educate
Research
Thank You To Our Generous 2020-2021 Donors
We greatly appreciate our members who have chosen to give a financial contribution to the AIHA. Our programs would not exist without your generosity! We'd like to extend a special thank you to the following:
Donors contributing $500 or more:
Erin Anderson
Adam Beaton
Chan Zuckerberg Initiative DAF
Robert and Kim Beaton
Jan Brandt
Chris and John Browner
Bob & Lisa Drew Charitable Fund
Andrew Eye and Kate Williams
Intercept Pharmaceuticals
Indiana University, Division of
Gastroenterology and Hepatology
Lilly Endowment
Liz LaHaye
Craig Lammert
Rodger and Jennifer Landau
Alysoun Mahoney
Brenda Marquez
Usama Samaan
Sanguine
Silicon Valley Community Foundation
The Smith-Fuqua Foundation
Dax and Cameron Williamson
Monthly Donors:
Nathan Beaton
Janet Bliden
Daniela Croiala
Lisa Devereaux
Kristi Feeney
Beckie Hill
Kent and Susan Kinkade
Liz LaHaye
Brenda Milliken
Usama Samaan
Rachel Schmidt
Beverly Wells
Veronica D. Williams